Veyrier, Switzerland

Olivier Ciclet

This inventor holds 1 USPTO granted patent and 5 published patent applications and 1 EPO patent. Top assignee: Societe Des Produits Nestle S.a.. Active years: 2022.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Olivier Ciclet: Innovator in Neurological Disorder Treatment

Introduction

Olivier Ciclet is a notable inventor based in Veyrier, Switzerland. He has made significant contributions to the field of medical science, particularly in the treatment of neurological disorders. His innovative work has led to the development of a unique compound that holds promise for improving patient outcomes.

Latest Patents

Ciclet holds a patent for a polyketide compound and its derivatives, which are intended for use in the prevention and treatment of neurological disorders. The invention focuses on a compound that can promote lactate secretion, which is crucial for brain health. This patent represents a significant advancement in therapeutic options for individuals suffering from neurological conditions.

Career Highlights

Olivier Ciclet is associated with the renowned company Nestlé S.A., where he continues to work on innovative solutions in the health sector. His expertise and dedication to research have positioned him as a key player in the development of new treatments.

Collaborations

Ciclet collaborates with talented professionals in his field, including Denis Marcel Barron and Alexandre Grand-Guillaume-Perrenoud. These partnerships enhance the research and development process, fostering an environment of innovation and creativity.

Conclusion

Olivier Ciclet's contributions to the field of neurological disorder treatment through his patented polyketide compound highlight his role as an influential inventor. His work not only advances medical science but also offers hope for improved therapies for patients.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…